Open-label, multicenter, single-arm extension study to evaluate the long-term safety of GSK3511294 (depemokimab) in adult and adolescent participants with severe asthma with eosinophilic phenotype from studies 206713 or 213744 (AGILE)

COMMERCIAL CLINICAL TRIAL